Earn CME/CE in your profession:

Continuing Education Activity

Cetirizine is a medication used in the treatment of allergic rhinitis and urticaria. It is a second-generation antihistamine. This activity reviews the indications, action, and contraindications for cetirizine as a valuable agent in treating rhinitis and urticaria. This activity will highlight the mechanism of action, adverse event profile, and other key factors (e.g., off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, relevant interactions) pertinent for members of the interprofessional team in the treatment of patients using cetirizine.


  • Summarize the mechanism of action of cetirizine.
  • Outline the adverse effects of cetirizine.
  • Review the monitoring of cetirizine.
  • Explain how healthcare professionals should educate patients on the potential adverse effects of cetirizine, such as drowsiness and fatigue.


Cetirizine was FDA-approved in the United States as a prescription-only product in 1995, and later in 2007, it got approval as an over-the-counter medication. Derived from the first-generation antihistamine hydroxyzine, cetirizine does not cross the blood-brain barrier to the extent of its first-generation counterparts; as a result, cetirizine is an effective treatment of allergic rhinitis that simultaneously minimizes the possibility of adverse sedative effects. Cetirizine is a second-generation antihistamine that effectively relieves sneezing, rhinorrhea, and watery eyes associated with seasonal allergies and allergic rhinitis due to allergens such as dust mites and molds. Cetirizine is available as a prescription-only ophthalmic formulation to treat allergic conjunctivitis.

  • Cetirizine is an FDA-approved medication for the relief and treatment of allergic rhinitis and chronic urticaria.[1][2] 
  • Cetirizine also effectively reduces the severity of hives and significantly reduces pruritus in patients with idiopathic urticaria.[3]
  • Though cetirizine is safe to use to treat perennial allergic rhinitis and urticaria in adults and children over the age of 6 months, it is indicated for the treatment of seasonal allergies in adults and children two years and older.
  • Cetirizine is also safe to use in the geriatric population.
  • The ophthalmic formulation of cetirizine is FDA approved to treat allergic conjunctivitis.[4]

Mechanism of Action

Cetirizine is a fast-acting, highly selective antagonist of the peripheral histamine H1-receptor. The H1-receptors inhibited by cetirizine are primarily on respiratory smooth muscle cells, vascular endothelial cells, immune cells, and the gastrointestinal tract. Unlike first-generation antihistamines such as diphenhydramine and doxylamine, cetirizine does not cross the blood-brain barrier to a large extent, avoiding the neurons of the central nervous system. As a result, cetirizine produces minimal sedation compared to many of the first-generation antihistamines.[5]

Given its antagonism of histamine H1-receptors, cetirizine effectively reverses many of the effects of histamine. Like other second-generation antihistamines, cetirizine decreases vascular permeability, decreasing the amount of fluid escaping to tissues from capillaries.  Cetirizine is also an inhibitor of histamine-induced bronchospasm.[6]

Cetirizine has been found to exert significant anti-inflammatory activity, reducing the infiltration of inflammatory cells in the setting of allergic rhinitis.[7] Specifically, research has found that cetirizine minimizes the migration of neutrophils and eosinophils.[8]


The dosing of cetirizine depends on patient age. In adults and children 12 years or older, the recommended dose is 5 or 10 mg per day orally, depending on symptom severity.[9] It is available in 5 mg and 10 mg tablets and 5 mg/ 5 ml oral solution and elixir. The ophthalmic formulation is available as 0.24% cetirizine hydrochloride eye drops in 5 mL and 7.5 mL bottles.

  • In children 6 to 11 years old, 5 or 10 mg (1 or 2 teaspoons) once daily in syrup form is recommended depending on symptom severity.[10]
  • In children 2 to 5 years old, the recommended dose is 2.5 mg (half teaspoon) in syrup form once daily.
  • In children six months to 23 months old, the recommended dose is 2.5 mg (half teaspoon) in syrup form once daily.
  • One drop (0.24% cetirizine hydrochloride ophthalmic solution) is instilled in the affected eye twice daily for patients with allergic conjunctivitis.


Cetirizine is absorbed rapidly in the gastrointestinal tract and undergoes substantial excretion by the kidney. Cetirizine reaches peak plasma concentration after approximately one hour. Its effects typically begin after 20 to 60 minutes and persist for at least 24 hours. Notably, cetirizine does not undergo significant metabolism and is not a metabolite of the CYP450 system.[11][12]

Specific Population

Breastfeeding Women: Occasional and small doses of cetirizine are acceptable while breastfeeding. Prolonged use of larger doses may cause a decrease in the milk supply or drowsiness and other adverse effects in the infant, particularly in combination with pseudoephedrine.[13]

Pregnant Women: It is US FDA pregnancy category B medicine.[14][15]

Hepatic Impairment: According to manufacturers prescribing information, 12 years and older patients with hepatic impairment should reduce the dose to 5 mg once daily. The manufacturer also recommends lowering the dose for 6 to 11 years old patients with hepatic impairment.

Renal Impairment: According to manufacturers prescribing information, 12 years and older patients with decreased renal function (CrCL 11-31 mL/min) and patients on hemodialysis (CrCL less than 7 mL/min) should reduce the dose to 5 mg once daily. The manufacturer also recommends lowering the dose for 6 to 11 years old patients with renal impairment.

Ophthalmic Formulation: Each bottle of 0.24% cetirizine hydrochloride contains benzalkonium chloride and can be absorbed by contact lenses. Manufacturers advise patients to remove contact lenses before instilling eye drops and wait for 10 min until reinsertion of lenses. If irritation or redness persists after this precaution, then avoid the use of contact lenses. It is proven safe and effective for pediatric patients two years and above in clinical studies.

Adverse Effects

Cetirizine is safe and relatively well-tolerated for the treatment of allergic rhinitis and urticaria. Although uncommon, its primary adverse effects in adults include somnolence, fatigue, Pharyngitis, dizziness, and dry mouth.[1]

Somnolence, as a result of cetirizine, appears to be dose-related. In some patients, research and experience have found cetirizine to contribute to daytime sleepiness.[16]

Children taking cetirizine most commonly experience similar side effects as adults taking cetirizine (somnolence, fatigue, and dry mouth). Children, in particular, are more likely than adults to experience headaches while taking cetirizine.[17]

In pediatric patients aged 2 to 11 years, the majority of adverse reactions reported with cetirizine were mild or moderate. Among all, somnolence appeared to be dose-related and abdominal pain was considered treatment-related.

While on cetirizine therapy, few cases of transient, reversible hepatic transaminase elevations have been reported in the literature. Some reports exist of hepatitis with elevated bilirubin too. In postmarketing studies, rare, potentially severe adverse events like severe hypotension, anaphylaxis, hemolytic anemia, cholestasis, orofacial dyskinesia, glomerulonephritis, hepatitis, stillbirth, and thrombocytopenia are reported.[18]

Ophthalmic formulation's common adverse reactions are local pain at the instillation site, ocular hyperemia, and decreased visual acuity.


Cetirizine is contraindicated in anyone with a known hypersensitivity to it or any of its ingredients. Cetirizine is also contraindicated in anyone with a known hypersensitivity to hydroxyzine, as cetirizine is a metabolite of hydroxyzine.

Patients should not use cetirizine concurrently with alcohol or other central nervous system depressants as it may cause dose-related sedation.[19]

There are few well-controlled human studies on cetirizine in pregnant mothers, although these showed it to be safe during pregnancy in animal studies. Cetirizine should be used in pregnancy only when necessary. First-generation antihistamines, such as diphenhydramine and doxylamine, are safest to use during pregnancy.[14] However, first-generation antihistamines are more likely than second-generation antihistamines to cause somnolence; as such, patients should understand the potential adverse effects of whatever medication they choose to take in pregnancy.

Cetirizine is not recommended for nursing mothers as it gets excreted in breast milk.


Patients taking cetirizine require monitoring for the relief of symptoms. Healthcare team members should also monitor patients for adverse effects such as fatigue and somnolence in adults and headaches in children.

The kidney primarily excretes cetirizine; as a result, the risk of toxicity is typically higher in patients with impaired renal function. Patients with renal impairment should take a lower dosage of medication in their age bracket.[20]

Liver function and liver enzymes in patients with hepatic involvement should have close monitoring also. Healthcare providers should make dosage adjustments as needed for patients with hepatic impairment.[21]


Research showed the minimal lethal dose to be approximately 460 times the maximum recommended daily dose for adults in rats. The primary target of acute toxicity in rodents was the central nervous system. The primary target of multiple-dose toxicity in rodents was the liver. A small number of cases of cetirizine overdose appear in the literature. However, many overdoses of cetirizine in children result from improper medication storage by adults living in the same home. Most overdose incidents that occur in children resolve spontaneously, with drowsiness and sedation being the main adverse effects observed. 

Drug-induced liver damage is common with numerous medications; there are reports of a small number of cases of cetirizine-induced liver damage; in all cases, liver enzyme values returned to normal after cessation of cetirizine.[22]

An adult overdosed on 150 mg cetirizine had somnolence but did not have abnormal blood chemistry, hematology results, or other clinical signs. An infant overdosed on 180 mg cetirizine, experienced restlessness, irritability, followed by drowsiness. Several hours after an accidental overdose of cetirizine, the six-year-old child presented with fixed and dilated pupils, tachycardia, agitation, hyperthermia, and hallucinations, consistent with anticholinergic toxicity.[23] There is no known specific antidote to cetirizine, and it can not be effectively removed by dialysis. When overdosed on cetirizine, treatment should be supportive and symptomatic, considering any concomitantly ingested medications.[24]

Enhancing Healthcare Team Outcomes

Cetirizine is a relatively safe and effective medication for the treatment of allergic rhinitis, urticaria, and allergic conjunctivitis. As cetirizine is also available over-the-counter, prescribers should educate patients on possible side effects, such as drowsiness, fatigue, and dry mouth, while dispensing medicine. Health care providers should be careful when prescribing cetirizine to patients with impaired renal or hepatic function. Ophthalmologists should educate contact lens wearers to exercise precautions and direct proper use of eyedrops. Patients using eye drops should be informed that local pain at the instillation site, ocular hyperemia, and decreased visual acuity are common adverse reactions with the ophthalmic formulation. Nurses should monitor therapeutic success and consult patients not to combine cetirizine with drugs that cause central nervous system depression. Pharmacists should perform a thorough medication review and verify that the patient is not taking any medications or supplements that could exacerbate cetirizine's adverse effects. Physicians, nurses, and pharmacists who prescribe or recommend cetirizine to patients should also provide information on the safe storage of cetirizine to prevent accidental overdose by children. Communication and collaboration among the interprofessional teams can achieve the best patient outcomes and reduce healthcare service utilization costs. [Level 5]

Article Details

Article Author

Aasim Naqvi

Article Editor:

Valerie Gerriets


11/27/2021 3:28:54 AM

PubMed Link:




Gehanno P,Bremard-Oury C,Zeisser P, Comparison of ebastine to cetirizine in seasonal allergic rhinitis in adults. Annals of allergy, asthma     [PubMed PMID: 8673684]


Guevara-Gutierrez E,Bonilla-Lopez S,Hernández-Arana S,Tlacuilo-Parra A, Safety and efficacy of cetirizine versus cetirizine plus ranitidine in chronic urticaria: Double-blind randomized placebo-controlled study. The Journal of dermatological treatment. 2015     [PubMed PMID: 25886090]


Garg G,Thami GP, Comparative efficacy of cetirizine and levocetirizine in chronic idiopathic urticaria. The Journal of dermatological treatment. 2007;     [PubMed PMID: 17365263]


Malhotra RP,Meier E,Torkildsen G,Gomes PJ,Jasek MC, Safety of cetirizine ophthalmic solution 0.24% for the treatment of allergic conjunctivitis in adult and pediatric subjects. Clinical ophthalmology (Auckland, N.Z.). 2019     [PubMed PMID: 30858690]


Gupta A,Chatelain P,Massingham R,Jonsson EN,Hammarlund-Udenaes M, Brain distribution of cetirizine enantiomers: comparison of three different tissue-to-plasma partition coefficients: K(p), K(p,u), and K(p,uu). Drug metabolism and disposition: the biological fate of chemicals. 2006 Feb;     [PubMed PMID: 16303872]


Tashkin DP,Brik A,Gong H Jr, Cetirizine inhibition of histamine-induced bronchospasm. Annals of allergy. 1987 Dec;     [PubMed PMID: 2892450]


Ciprandi G,Tosca MA,Milanese M,Ricca V, Cetirizine reduces cytokines and inflammatory cells in children with perennial allergic rhinitis. European annals of allergy and clinical immunology. 2004 Jun;     [PubMed PMID: 15329007]


Townley RG,Okada C, Use of cetirizine to investigate non-H1 effects of second-generation antihistamines. Annals of allergy. 1992 Feb;     [PubMed PMID: 1346737]


DuBuske L, Dose-ranging comparative evaluation of cetirizine in patients with seasonal allergic rhinitis. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 1995 Apr     [PubMed PMID: 7719897]


Jobst S,van den Wijngaart W,Schubert A,van de Venne H, Assessment of the efficacy and safety of three dose levels of cetirizine given once daily in children with perennial allergic rhinitis. Allergy. 1994 Sep     [PubMed PMID: 7653736]


OTC drugs for seasonal allergies. The Medical letter on drugs and therapeutics. 2019 Apr 22;     [PubMed PMID: 31169808]


Kuna P,Jurkiewicz D,Czarnecka-Operacz MM,Pawliczak R,WoroĊ„ J,Moniuszko M,Emeryk A, The role and choice criteria of antihistamines in allergy management - expert opinion. Postepy dermatologii i alergologii. 2016 Dec;     [PubMed PMID: 28035215]


Cetirizine Drugs and Lactation Database (LactMed). 2006     [PubMed PMID: 30000569]


Golembesky A,Cooney M,Boev R,Schlit AF,Bentz JWG, Safety of cetirizine in pregnancy. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology. 2018 Oct;     [PubMed PMID: 29565188]


Mazzotta P,Loebstein R,Koren G, Treating allergic rhinitis in pregnancy. Safety considerations. Drug safety. 1999 Apr     [PubMed PMID: 10230583]


Ozdemir PG,Karadag AS,Selvi Y,Boysan M,Bilgili SG,Aydin A,Onder S, Assessment of the effects of antihistamine drugs on mood, sleep quality, sleepiness, and dream anxiety. International journal of psychiatry in clinical practice. 2014 Aug;     [PubMed PMID: 24673474]


Nayak AS,Berger WE,LaForce CF,Urdaneta ER,Patel MK,Franklin KB,Wu MM, Randomized, placebo-controlled study of cetirizine and loratadine in children with seasonal allergic rhinitis. Allergy and asthma proceedings. 2017 May 1     [PubMed PMID: 28441993]


Rajput A,Baerg K, Cetirizine-induced dystonic movements. Neurology. 2006 Jan 10     [PubMed PMID: 16401869]


Vermeeren A,Ramaekers JG,O'Hanlon JF, Effects of emedastine and cetirizine, alone and with alcohol, on actual driving of males and females. Journal of psychopharmacology (Oxford, England). 2002 Mar;     [PubMed PMID: 11949773]


Matzke GR,Yeh J,Awni WM,Halstenson CE,Chung M, Pharmacokinetics of cetirizine in the elderly and patients with renal insufficiency. Annals of allergy. 1987 Dec     [PubMed PMID: 2892446]


Cetirizine LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012     [PubMed PMID: 31643739]


Cetirizine-induced hepatotoxicity: case series and review of the literature., Coskun A,Yavasoglu I,Yasa MH,Culhaci N,Yukselen V,, Gastroenterology report, 2016 Aug 29     [PubMed PMID: 27576471]


Renko A,Cortese T,Karagiannis P,Salzman M, Unintentional cetirizine overdose causing anticholinergic syndrome: A case report. The American journal of emergency medicine. 2021 Aug 25     [PubMed PMID: 34474941]


Ridout SM,Tariq SM, Cetirizine overdose in a young child. The Journal of allergy and clinical immunology. 1997 Jun     [PubMed PMID: 9215262]